Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01470404
NCT01470404
Completed
Not Applicable

Pharmacogenomic Study to Predict Toxicity and Response in Gastric Cancer Patients Treated With Adjuvant Chemotherapy

Samsung Medical Center1 site in 1 country792 target enrollmentJuly 10, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGastric Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastric Cancer
Sponsor
Samsung Medical Center
Enrollment
792
Locations
1
Primary Endpoint
germline polymorphisms in xenobiotic metabolism genes in toxicity profile
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

To assess the role of germline polymorphisms in xenobiotic metabolism genes in toxicity profile.

To assess the role of germline polymorphisms in genes associated with DNA repair, p53 tumor suppressor gene and angiogenesis pathway in predicting recurrence and survival in gastric cancer patients treated with adjuvant chemotherapy.

Registry
clinicaltrials.gov
Start Date
July 10, 2008
End Date
July 10, 2013
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Won Ki Kang

Professor of Medicine, Sungkyunkwan University School of Medicine, Department of Hematology and Oncology

Samsung Medical Center

Eligibility Criteria

Inclusion Criteria

  • •gastric cancer patients treated with adjuvant chemotherapy

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

germline polymorphisms in xenobiotic metabolism genes in toxicity profile

Time Frame: 36 months

Study Sites (1)

Loading locations...

Similar Trials

Withdrawn
Not Applicable
Urine Toxicology With Pharmacogenomic Interpretation Assay: UTOPIAUrine Toxicology
NCT02096172Renaissance RX
Recruiting
Not Applicable
Pharmacogenetic Determinants Of Treatment Response In ChildrenAll MalignanciesChildren Being Treated for Catastrophic Illness
NCT00730678St. Jude Children's Research Hospital8,800
Completed
Not Applicable
Case-Control Viramune (Nevirapine) Toxicogenomics StudyHIV Infections
NCT00310843Boehringer Ingelheim889
Completed
Not Applicable
Pharmacogenomic Research in Korean Patients With Hepatitis CChronic Hepatitis C
NCT01453244Inje University373
Completed
Phase 2
The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian PatientsNon Small Cell Lung CancerBreast Cancer
NCT00695994National University Hospital, Singapore300